ACADIA Awarded Grant from The Michael J. Fox Foundation

The grant of up to $830,000 was awarded under the Foundation’s Therapeutics Development Initiative aimed at supporting preclinical development of Parkinson’s disease therapies. Bo-Ragnar Tolf, Ph.D. MD, Vice President, Chemistry and Roger Olsson, Ph.D. Director, Medicinal Chemistry explains.